TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Insulin secretion/insulin resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: professional performance enhancement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-confidence improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quality of care improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global rating of emotionalism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tearfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VAS values decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPT differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG activity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional coupling between the amygdala and orbitofrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rescue medication usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: preferences for a patient‐centered versus a biomedical communication style
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NK cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean seizure occurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: psychological quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioural disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: yearly ENT infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: respiratory obstruction symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite wound complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery index of conditioned nBR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in morning pre-dose trough forced expiratory volume in 1 s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average daily rescue medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Self-Administered Computerized Transition Dyspnea Index focal score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in 2hPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in 24hUG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ratio of n-6 to n-3 fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Faculty use of EBM sources
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of EB‐CME quality and value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean total morphine usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: LDKT actions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in self-reported DI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower in-vivo urges to neutralize intrusive thoughts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in disease-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in pro-inflammatory cytokine levels (IL-6, VEGF, TNF-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cardiac related knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: health responsibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nutritional behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Onset of pulpal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived increase in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: smoking quit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pooled NPV of neoplastic lesion identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Agreement of proposed surveillance intervals with histologic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HTN
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of CKD
Endpoint domain: Mortality/survival
Primary endpoint: total medical cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: inpatient cost
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in trained tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: alpha band power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of chemosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of eyelid swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of redness and itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of ≥ 15 ODI points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of employment at 8-year follow-up
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: median remission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS for nasal obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QT variability (QTVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Apolipoprotein B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting gastrin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of corpus atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: oral health knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCa-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Length of stay in the IMC unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction in endotoxin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choroidal thickness variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hirsutism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tegner activity scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intra-operative and postpartum blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in preoperative and postoperative hematocrit values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cumulative rate of adenomas detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative rate of advanced adenomas detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adjudicated serious cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Total white matter hyperintensity area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: total trajectory length of COP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sum of all skinfold measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of subjects who maintained virologic suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICTP as a predictor of all cause death
Endpoint domain: Mortality/survival
Primary endpoint: Dermal collagen remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of interstitial cystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urinary outcomes
Primary endpoint: Lipidomic signature in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in liver histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV DNA <400 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of TDF
Endpoint domain: Adverse events/effects
Primary endpoint: lower viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reduced HR‐HPV high LA band intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Memory for happy faces
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of change on the MMSE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HD-induced PMN degranulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survival rates for tooth loss at 10 years
Endpoint domain: Mortality/survival
Primary endpoint: Time to first tooth loss in the study arch
Endpoint domain: Mortality/survival
Primary endpoint: Pain app satisfaction ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Analgesia onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical and mental scores (SF‐8 and SF‐36 QOL health surveys)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HAMD Item 3 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total symptom score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: unusual, high-pitched crying
Endpoint domain: Adverse events/effects
Primary endpoint: prolonged crying
Endpoint domain: Adverse events/effects
Primary endpoint: mean inhomogeneity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean stomach deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delivery rate of antibiotic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEINES-QOL scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Villalta scale scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scapulohumeral rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: catheter-related sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: real-life functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 6-month change on the SF-36 vitality scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of EPSs measured as wakefulness activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean intelligence quotient
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Raven's CPM score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Supportive behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental Beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Elasticity of the cerebral blood vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Speed of blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal clearance of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: growth response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9-month angiographic in-stent late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: occurrence of major adverse cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: Distance walked at 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of surgery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: better recovery to functional independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lower costs at 1 year after hemorrhage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Subjective sense of smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of cystic fibrosis testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Uptake of screening for Down's syndrome
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Anxiety later in pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Major adverse cardiac events (death, myocardial infarction, or stroke)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Eye Dryness Symptoms (EDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Unresponsiveness (SU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum ALT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cellular cholesterol efflux to serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in physical activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rates of stage progression
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shock success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of six cycles of IP therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fistula/pulmonary-lung complications (air leak)
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving preferred flow rate of >60 L/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean number of hemolytic bacteria on dentist's mask
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HVA and IMA angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: walking distance on treadmill
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recall of facial nerve paralysis complications
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of PPCs
Endpoint domain: Adverse events/effects
Primary endpoint: undetectable serum HBV-DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative conversion rate of hepatitis B e antigen (HBeAg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of HBeAg seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular event-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Patients' tolerance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient movement during colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in nasal obstruction symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight for height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type II fibre size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Satellite cell content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Myonuclear domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 2-year rates of intrauterine pregnancy (IUP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Improvement in heart left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreased lactate dehydrogenase (LDH) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased plasma concentrations of coenzyme Q10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Esophageal varices presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aspartate aminotransferase to platelet ratio index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound-healing period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility on days 15 and 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength on day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of air-bone gaps smaller than 10 dB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in symptoms of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual analogue scale (AUCVAS) for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rescue morphine analgesia requirement
Endpoint domain: Adverse events/effects
Primary endpoint: mean power loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants maintaining at least 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weight (kg) from randomization to week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum pain level at rest and at walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxford knee score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Force degradation of Ni-Ti wires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonresponse rate to clopidogrel
Endpoint domain: Adverse events/effects
Primary endpoint: early complications
Endpoint domain: Adverse events/effects
Primary endpoint: follow-up visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in MI risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(total)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC(ppg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: wrist extensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hospital admissions for respiratory problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: need for special schooling
Endpoint domain: Life impact
Endpoint subdomain: Educational functioning
Primary endpoint: Mean apparent clearance of oral vinorelbine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute clearance of intravenous vinorelbine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC fatty acid membrane composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood concentrations of markers of vascular inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: blood concentrations of markers of endothelial dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: blood concentrations of markers of hypercoagulability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean decrease in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily insulin usage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Steward Recovery Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of perioperative amnesia
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning